Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,108 public trials 620 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML)

NCT03512197

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • University of Chicago Medical Center . Chicago, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Oregon Health and Science Univ Portland, Oregon, United States
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
View all 133 locations
View Trial Details
Completed

Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent Line

NCT05734053

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Novartis Investigative Site Freudenstadt, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Aschaffenburg, Bavaria, Germany
  • Novartis Investigative Site Augsburg, Bavaria, Germany
  • Novartis Investigative Site Bayreuth, Bavaria, Germany
View all 77 locations
View Trial Details
Completed

A Study of Cusatuzumab Plus Azacitidine in Japanese Participants With Newly Diagnosed Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome Who Are Not Candidates for Intensive Treatment

NCT04241549

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • Fukushima Medical University Hospital Fukushima, Japan
  • Gunmaken Saiseikai Maebashi Hospital Maebashi, Japan
  • Osaka City General Hospital Osaka, Japan
  • NTT Medical Center Tokyo Tokyo, Japan
View Trial Details
Completed

Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction Therapy

NCT03435848

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Augusta University Georgia Cancer Center Augusta, Georgia, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • Franciscan Physician Network Oncology and Hematology Specialists Indianapolis, Indiana, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View all 16 locations
View Trial Details

Related conditions